| Medical Costs Payable [Text Block] |
Medical Costs PayableThe following table shows the components of the change in medical costs payable for the years ended December 31: | | | | | | | | | | | | | | | | | | | | | | (in millions) | | 2025 | | 2024 | | 2023 | | Medical costs payable, beginning of period | | $ | 34,224 | | | $ | 32,395 | | | $ | 29,056 | | | Acquisitions (dispositions), net | | 32 | | | (755) | | | 1 | | | Reported medical costs: | | | | | | | | Current year | | 313,463 | | | 264,885 | | | 242,734 | | | Prior years | | (140) | | | (700) | | | (840) | | | Premium deficiency and loss contracts reserves | | 672 | | | — | | | — | | | Total reported medical costs | | 313,995 | | | 264,185 | | | 241,894 | | | Medical payments: | | | | | | | Payments for current year | | (277,135) | | | (231,890) | | | (211,380) | | | Payments for prior years | | (31,290) | | | (29,532) | | | (27,176) | | | Total medical payments | | (308,425) | | | (261,422) | | | (238,556) | | | Less: increase in medical costs payable included within businesses held for sale | | (489) | | | (179) | | | — | | | Medical costs payable, end of period | | $ | 39,337 | | | $ | 34,224 | | | $ | 32,395 | |
For the years ended December 31, 2025, 2024 and 2023, prior years’ medical cost reserve development included no individual factors that were significant. Medical costs payable included IBNR of $26.7 billion and $23.7 billion at December 31, 2025 and 2024, respectively. Substantially all of the IBNR balance as of December 31, 2025 relates to the current year. The following is information about incurred and paid medical cost development as of December 31, 2025: | | | | | | | | | | | | | | | | | Net Incurred Medical Costs | | (in millions) | | For the Years Ended December 31, | | Year | | 2024 | | 2025 | | 2024 | | $ | 264,885 | | | $ | 264,550 | | | 2025 | | | | 313,463 | | | Changes in premium deficiency and loss contracts reserves | | | | 672 | | | Total | | | | $ | 578,685 | | | | | | | | | Net Cumulative Medical Payments | | (in millions) | | For the Years Ended December 31, | | Year | | 2024 | | 2025 | | 2024 | | $ | (231,890) | | | $ | (262,318) | | | 2025 | | | | (277,135) | | | Total | | | | (539,453) | | | Net remaining outstanding liabilities prior to 2024 | | | | 562 | | | Acquisitions | | | | 32 | | | Increase in medical costs payable included within businesses held for sale | | | | (489) | | | Total medical costs payable | | | | $ | 39,337 | |
|